Skip to main content
. 2024 Nov 14;16(11):7310–7319. doi: 10.21037/jtd-24-831

Table 2. Underlying pulmonary conditions and their effect on 106 chronic pulmonary aspergillosis.

Underlying pulmonary diseases Patients Kaplan-Meier analysis
1-year survival (%) 3-year survival (%) P value
(log-rank test)
With Without With Without
COPD 23 (21.7) 73±9.5 92.7±2.9 84.5±4.4 0.21
Lung tuberculosis 7 (7.1) 85.7±13.2 90.8±2.9 86.2±3.6 0.94
Emphysema 37 (34.9) 75.2±7.2 92.6±3.2 64.9±9.3 85.9±4.8 0.02
NTM 6 (5.7) 83.3±15.2 91±2.9 86.4±3.5 0.89
Bronchiectasis 75 (70.8) 91.9±3.2 76.2±7.9 86.6±4.2 33.4±24.1 0.052
Lung cancer 8 (7.5) 14.6±13.5 90.8±2.9 88.3±3.3 <0.001
Lung tuberculosis scarring 25 (23.6) 77.9±8.8 91.3±3.1 62.3±15.6 83.6±4.4 0.28

Data are presented as mean ± standard deviation or n (%). COPD, chronic obstructive pulmonary disease; NTM, non-tuberculous mycobacterium.